Recent Company News

• 05:00 PM ET Feb 10, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:58 AM ET May 08, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:12 AM ET May 08, 2025
  

  Centessa Pharmaceuticals initiated buy at Chardan Capital ($12.11, 0.00)

• 03:57 AM ET Mar 31, 2025
  

  Centessa Pharmaceuticals initiated overweight at Piper Sandler ($14.59, 0.00)

• 07:02 AM ET Mar 24, 2025
  

  Centessa Pharmaceuticals reports Q4 EPS ($0.84) vs FactSet ($0.42) [8 est, ($0.73)-(0.31)]

• 04:03 PM ET Feb 21, 2025
  

  Centessa Pharmaceuticals enters license agreement with Genmab A/S for LockBody platform ($16.63, 0.00)

• 11:23 AM ET Feb 10, 2025
  

  StreetAccount Summary - US unusual volume traders